Novo Nordisk (NVO) will be forced to lower employee bonuses in its home country, Denmark, as the company doubles down on a ...

According to Bloomberg, the reduction in bonuses will apply to employees who are eligible for short-term incentives in ...

COPENHAGEN (Reuters) -As Novo Nordisk's sales of its blockbuster weight-loss drug Wegovy boomed, the Danish drugmaker raced ...

No one stays on top forever. It’s a lesson that Ozempic maker Novo Nordisk may be painfully learning about. The Danish ...

Novo Nordisks stock has tumbled from record highs after slashing its 2025 outlook, as fierce competition, leadership changes, ...

Nykredit A/S, one of Denmark’s largest banks, slashed its outlook for the Danish economy after pharmaceutical giant Novo Nordisk A/S warned of weaker earnings growth and raised fears of a broader ...

Through innovation, cost discipline, legal action, and competitive pricing, Novo Nordisk has reasserted its leadership in the GLP-1 market. With a robust pipeline and global expansion, NVO is poised ...

A competitor reported a successful late-stage clinical trial of a drug that could be very competitive with Wegovy.

U.S.-listed shares of Novo Nordisk fell sharply for a second straight day Wednesday, this time after Bank of America ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

COPENHAGEN, Denmark, April 29, 2025 /PRNewswire/ -- The Novo Nordisk Foundation today announced the latest edition of its annual Challenge Programme, where for the first time it is inviting ...

Hyderabad-based Natco Pharma, through its legal representative, reportedly stated that it had reached out to the Danish drugmaker multiple times in recent months to discuss its non-infringing patents ...